LRIG2 Gene Urofacial Syndrome NGS Genetic DNA Test

Introduction

The LRIG2 Gene Urofacial Syndrome NGS Genetic DNA Test is a specialized genetic test that plays a pivotal role in diagnosing Urofacial Syndrome, a condition linked to the LRIG2 gene. This syndrome can lead to a range of symptoms affecting the urinary system and facial features. By utilizing Next-Generation Sequencing (NGS) technology, this test provides detailed insights into the genetic makeup of individuals, helping clinicians to make informed decisions about patient care.

What the Test Measures

This test detects mutations in the LRIG2 gene, which are associated with Urofacial Syndrome. By analyzing the genetic sequence, healthcare providers can identify specific alterations that may contribute to the symptoms observed in patients.

Who Should Consider This Test

Individuals who exhibit symptoms of Urofacial Syndrome or have a family history of the condition should consider undergoing this test. Common symptoms include:

• Facial dysmorphology
• Urinary tract abnormalities
• Renal issues

Additionally, those with a clinical history that suggests a genetic component to their symptoms may benefit from this testing.

Benefits of Taking the Test

• Accurate diagnosis of Urofacial Syndrome
• Informed treatment options based on genetic findings
• Guidance for family planning and risk assessment for relatives
• Access to specialized care and support services

Understanding Your Results

Results from the LRIG2 Gene Urofacial Syndrome NGS Genetic DNA Test typically take 3 to 4 weeks. Once results are available, healthcare providers will discuss the findings in detail, explaining any mutations found and their implications for health and treatment options.

Test Pricing

We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. For your convenience, we also offer home sample collection services. To book your test or for more information, please call or WhatsApp us at +254711564616.